Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionLcnb Corp
Latest Disclosed Ownership5,190 shares
Latest Disclosed Value $ 314,774
Lcnb Corp reports 4.01% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 11, 2026 - Lcnb Corp filed a 13F-HR form disclosing ownership of 5,190 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $272,060 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 4,990 shares of Bristol-Myers Squibb Company. This represents a change in shares of 4.01% during the quarter. The current value of the position is $246,188 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Bristol-Myers Squibb Common Stock 110122108 5,190 200 4.01 315 16.73 0.1058
2026-02-10 2025-12-31 13F Bristol-Myers Squibb Common Stock 110122108 4,990 240 5.05 269 25.70 0.0902
2025-11-10 2025-09-30 13F Bristol-Myers Squibb Common Stock 110122108 4,750 -50 -1.04 214 -3.60 0.0750
2025-08-11 2025-06-30 13F Bristol-Myers Squibb Common Stock 110122108 4,800 0 0.00 222 -23.97 0.0782
2025-05-12 2025-03-31 13F Bristol-Myers Squibb Common Stock 110122108 4,800 0 0.00 293 7.75 0.1078
2025-02-11 2024-12-31 13F Bristol-Myers Squibb Common Stock 110122108 4,800 -11 -0.23 271 9.27 0.0990
2024-11-12 2024-09-30 13F Bristol-Myers Squibb Common Stock 110122108 4,811 4,811 249 0.0882
2024-08-14 2024-06-30 13F Bristol-Myers Squibb Common Stock 110122108 0 -5,211 -100.00 0 -100.00
2024-05-10 2024-03-31 13F Bristol-Myers Squibb Common Stock 110122108 5,211 -608 -10.45 283 -5.37 0.1022
2024-02-12 2023-12-31 13F Bristol-Myers Squibb Common Stock 110122108 5,819 -89 -1.51 299 -12.87 0.1174
2023-11-13 2023-09-30 13F Bristol-Myers Squibb Common Stock 110122108 5,908 -1,353 -18.63 343 -26.29 0.1517
2023-08-14 2023-06-30 13F Bristol-Myers Squibb Common Stock 110122108 7,261 -1,301 -15.20 464 -21.75 0.1980
2023-05-03 2023-03-31 13F Bristol-Myers Squibb Common Stock 110122108 8,562 0 0.00 593 -3.73 0.2684
2023-02-10 2022-12-31 13F Bristol-Myers Squibb Common Stock 110122108 8,562 100 1.18 616 2.33 0.2860
2022-11-14 2022-09-30 13F Bristol-Myers Squibb Common Stock 110122108 8,462 -312 -3.56 602 -10.95 0.3271
2022-08-12 2022-06-30 13F Bristol-Myers Squibb Common Stock 110122108 8,774 0 0.00 676 5.46 0.3504
2022-05-13 2022-03-31 13F Bristol-Myers Squibb Common Stock 110122108 8,774 0 0.00 641 17.18 0.3012
2022-02-14 2021-12-31 13F Bristol-Myers Squibb Common Stock 110122108 8,774 -37 -0.42 547 4.99 0.2500
2021-11-12 2021-09-30 13F Bristol-Myers Squibb Common Stock 110122108 8,811 -260 -2.87 521 -14.03 0.2630
2021-08-13 2021-06-30 13F Bristol-Myers Squibb Common Stock 110122108 9,071 100 1.11 606 7.07 0.3049
2021-05-13 2021-03-31 13F Bristol-Myers Squibb Common Stock 110122108 8,971 -510 -5.38 566 -3.74 0.3085
2021-02-12 2020-12-31 13F Bristol-Myers Squibb Common Stock 110122108 9,481 -20 -0.21 588 2.62 0.3332
2020-11-12 2020-09-30 13F Bristol-Myers Squibb Common Stock 110122108 9,501 -510 -5.09 573 -2.72 0.3746
2020-08-12 2020-06-30 13F Bristol-Myers Squibb Common Stock 110122108 10,011 0 0.00 589 5.56 0.3979
2020-05-11 2020-03-31 13F Bristol-Myers Squibb Common Stock 110122108 10,011 88 0.89 558 -12.40 0.4357
2020-02-10 2019-12-31 13F BRISTOL MYERS SQUIBB Common Stock 110122108 9,923 1,657 20.05 637 52.03 0.3888
2019-11-08 2019-09-30 13F BRISTOL MYERS SQUIBB Common Stock 110122108 8,266 949 12.97 419 26.20 0.2685
2019-08-01 2019-06-30 13F BRISTOL MYERS SQUIBB Common Stock 110122108 7,317 -1 -0.01 332 -4.87 0.2331
2019-05-02 2019-03-31 13F BRISTOL MYERS SQUIBB Common Stock 110122108 7,318 -145 -1.94 349 -10.05 0.2526
2019-02-19 2018-12-31 13F BRISTOL MYERS SQUIBB Common Stock 110122108 7,463 275 3.83 388 -13.00 0.3202
2018-11-09 2018-09-30 13F BRISTOL MYERS SQUIBB Common Stock 110122108 7,188 -80 -1.10 446 10.95 0.3151
2018-08-13 2018-06-30 13F BRISTOL MYERS SQUIBB Common Stock 110122108 7,268 2,843 64.25 402 43.57 0.3630
2018-05-15 2018-03-31 13F BRISTOL MYERS SQUIBB Common Stock 110122108 4,425 372 9.18 280 12.90 0.2518
2018-02-13 2017-12-31 13F BRISTOL MYERS SQUIBB Common Stock 110122108 4,053 -514 -11.25 248 -15.07 0.2184
2017-11-13 2017-09-30 13F BRISTOL MYERS SQUIBB Common Stock 110122108 4,567 33 0.73 292 15.42 0.2741
2017-08-14 2017-06-30 13F BRISTOL MYERS SQUIBB Common Stock 110122108 4,534 26 0.58 253 3.27 0.2473
2017-05-12 2017-03-31 13F BRISTOL MYERS SQUIBB Common Stock 110122108 4,508 0 0.00 245 -6.84 0.2343
2017-02-14 2016-12-31 13F BRISTOL MYERS SQUIBB Common Stock 110122108 4,508 4,508 263 0.2599
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.